|
|
 |
Press Releases |
|
|
|
|
| |
Medication Delivery Headlines |
|
|
|
- Baxter's Antimicrobial IV Technology Now Shown to Kill Six Common Pathogens, Including MRSA and VRE [September 29, 2008]
- Baxter´s V-Link Luer-Activated Device with VitalShield Protective Coating Now Available for Hospitals [April 09, 2008]
- Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products [February 28, 2008]
- Baxter Provides Update on Heparin Reactions [February 11, 2008]
- Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/ML 10 and 30mL Multi-Dose Vials [January 25, 2008]
- Baxter Receives 510(k) Clearance from FDA for V-Link with VitalShield, New Antimicrobial Intravascular Technology [November 09, 2007]
- Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products [October 09, 2007]
- Baiyunshan Pharmaceutical and Baxter Finalize Joint Venture for Parenteral Nutrition Products in China [August 08, 2007]
- Baxter Provides Update on Service Documentation Class I Recall [August 07, 2007]
- FDA Classifies Baxter´s Voluntary Recall Action Regarding Service Documentation as a Class I Recall [July 25, 2007]
- FDA Classifies Baxter´s Field Corrective Action as a Class I Recall on Recently Manufactured or Upgraded COLLEAGUE Triple Channel Infusion Pumps (Models 2M8153, 2M8163 and 2M9163) [July 18, 2007]
- Baxter Receives Approval to Process ARALAST NP [May 09, 2007]
- Baxter Introduces HYLENEX for use in Ophthalmic Surgery [April 27, 2007]
- Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference [April 20, 2007]
- Baxter Receives 510(K) Clearance from FDA for COLLEAGUE Infusion Pumps [February 27, 2007]
- Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study [February 14, 2007]
- Halozyme And Baxter Expand Global HYLENEX Collaboration [February 14, 2007]
- Baxter Receives Clearance From U.S. FDA for Ipump Pain Management System 510(k) [February 06, 2007]
- Baxter Receives Conditional Approval for U.S. COLLEAGUE Infusion Pump Corrective Action Plan and Submits Updated 510(k) Pre-Market Notification [December 14, 2006]
- Baiyunshan and Baxter Announce Plans to Form Parenteral Nutrition Joint Venture in China [November 14, 2006]
- Baxter Announces Launch of BAXJECT II Needle-Less Transfer Device for ADVATE [October 11, 2006]
- Baxter and FDA Reach Agreement on Next Steps for U.S. Infusion Pumps [June 29, 2006]
- Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids [June 27, 2006]
- Baxter Receives Tentative FDA Approvals for Ondansetron Injection in Vials and Premix Containers [June 15, 2006]
- Baxter Announces New AVIVA Line of Intravenous Solutions [April 18, 2006]
- Baxter Announces Launch of Authorized Generic Azithromycin for Injection [March 23, 2006]
- Halozyme Therapeutics and Baxter Release Results from the INFUSE-LR Study [February 08, 2006]
- Baxter Announces Classification of Letter to Customers Regarding COLLEAGUE Infusion Pumps [February 02, 2006]
|
|
 |
| Headlines |
|
 |
|
|
|
|
|
|
|
Print this page
